Abhimanyu Garg Selected Research

Lipodystrophy

1/2022	Autoantibodies to Perilipin-1 Define a Subset of Acquired Generalized Lipodystrophy.
2/2019	Lipodystrophies, dyslipidaemias and atherosclerotic cardiovascular disease.
1/2019	Efficacy of Metreleptin Treatment in Familial Partial Lipodystrophy Due to PPARG vs LMNA Pathogenic Variants.
3/2018	A novel paraneoplastic syndrome with acquired lipodystrophy and chronic inflammatory demyelinating polyneuropathy in an adolescent male with craniopharyngioma.
11/2017	Metabolic, Reproductive, and Neurologic Abnormalities in Agpat1-Null Mice.
9/2017	Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
12/2016	The Diagnosis and Management of Lipodystrophy Syndromes: A Multi-Society Practice Guideline.
12/2016	Lipodystrophy Syndromes.
10/2015	A Novel Syndrome of Generalized Lipodystrophy Associated With Pilocytic Astrocytoma.
5/2013	Cholic acid for hepatic steatosis in patients with lipodystrophy: a randomized, controlled trial.

For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Abhimanyu Garg Research Topics

Disease

30	Lipodystrophy 01/2022 - 02/2002
23	Congenital Generalized Lipodystrophy (Berardinelli-Seip Congenital Lipodystrophy) 01/2022 - 05/2002
20	Hypertriglyceridemia 01/2022 - 02/2002
16	Insulin Resistance 11/2021 - 02/2002
9	Familial Partial Lipodystrophy (Dunnigan Syndrome) 02/2019 - 01/2002
9	Type 2 Diabetes Mellitus (MODY) 07/2017 - 06/2002
8	Diabetes Mellitus 03/2018 - 02/2002
5	Progeria (Hutchinson Gilford Syndrome) 10/2020 - 02/2006
5	Obesity 07/2016 - 10/2002
4	Hyperglycemia 01/2022 - 03/2003
4	Hypercholesterolemia 01/2021 - 05/2007
4	Hyperlipoproteinemia Type II (Familial Hypercholesterolemia) 01/2020 - 12/2012
4	Cardiomyopathies (Cardiomyopathy) 01/2019 - 02/2006
4	Muscular Diseases (Myopathy) 01/2019 - 05/2007
4	Dyslipidemias (Dyslipidemia) 11/2015 - 11/2002
3	Panniculitis 01/2022 - 12/2010
3	Neoplasms (Cancer) 01/2022 - 08/2010
3	Cardiovascular Diseases (Cardiovascular Disease) 01/2021 - 06/2011
3	Hyperlipoproteinemias 01/2018 - 11/2011
3	Xanthomatosis (Xanthoma) 01/2018 - 05/2014
3	Body Weight (Weight, Body) 11/2017 - 11/2006
3	Muscular Dystrophies (Muscular Dystrophy) 09/2017 - 02/2006
3	Anemia 05/2017 - 12/2010
3	Hyperlipidemias (Hyperlipidemia) 12/2016 - 01/2003
3	Coronary Disease (Coronary Heart Disease) 01/2016 - 05/2007
3	Weight Loss (Weight Reduction) 07/2014 - 06/2002
3	Pancreatitis 05/2014 - 05/2007
2	Hypertension (High Blood Pressure) 01/2020 - 09/2011
2	Limb-Girdle Muscular Dystrophies (Limb-Girdle Muscular Dystrophy) 12/2019 - 05/2002
2	Acquired Partial Lipodystrophy 02/2019 - 05/2002
2	Acanthosis Nigricans 01/2018 - 09/2010
2	Uterine Cervical Neoplasms (Cancer of the Cervix) 03/2011 - 08/2010
2	Thymoma (Thymic Carcinoma) 08/2009 - 06/2009
2	Dilated Cardiomyopathy (Cardiomyopathy, Congestive) 04/2006 - 05/2002
2	Laminopathies 04/2006 - 08/2003
2	Glucose Intolerance 12/2005 - 11/2002
2	Hyperinsulinism (Hyperinsulinemia) 03/2003 - 02/2002
1	Diabetes Complications 11/2021
1	Hepatitis 01/2021
1	Osteoporosis 08/2020

Drug/Important Bio-Agent (IBA)

21	Triglycerides (Triacylglycerol)IBA 01/2020 - 02/2002
17	Lamin Type A (Lamin A)IBA 10/2020 - 05/2002
16	Proteins (Proteins, Gene)FDA Link 01/2020 - 05/2002
15	Insulin (Novolin)FDA Link 01/2022 - 01/2003
12	LipidsIBA 08/2019 - 06/2002
11	Glucose (Dextrose)FDA LinkGeneric 11/2017 - 02/2002
10	LeptinIBA 01/2019 - 02/2002
9	HDL CholesterolIBA 01/2018 - 11/2002
6	metreleptinIBA 01/2022 - 03/2012
6	Metalloproteases (Metalloproteinases)IBA 10/2010 - 08/2003
6	ZincIBA 10/2010 - 08/2003
5	Fish OilsIBA 01/2022 - 03/2003
5	Fibric Acids (Fibrates)IBA 01/2022 - 03/2003
5	Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA 01/2021 - 03/2003
5	LDL Receptors (LDL Receptor)IBA 01/2020 - 05/2007
4	AutoantibodiesIBA 01/2022 - 11/2011
4	ApolipoproteinsIBA 01/2020 - 05/2007
4	LDL CholesterolIBA 01/2018 - 09/2011
4	Caveolin 1IBA 08/2009 - 04/2008
4	PPAR gammaIBA 08/2009 - 01/2002
3	1-Acylglycerol-3-Phosphate O-Acyltransferase (1 Acylglycerol 3 Phosphate O Acyltransferase)IBA 10/2020 - 10/2003
3	Phospholipids (Phosphatides)FDA LinkGeneric 11/2017 - 07/2003
3	SodiumIBA 05/2017 - 10/2011
3	Creatine Kinase (Creatine Phosphokinase)IBA 01/2017 - 09/2008
3	Lipoprotein Lipase (Diacylglycerol Lipase)IBA 01/2017 - 05/2007
3	Dietary Fats (Dietary Fat)IBA 11/2016 - 12/2007
3	CholesterolIBA 05/2014 - 06/2002
3	CalciumIBA 10/2011 - 11/2006
3	EnzymesIBA 01/2006 - 07/2003
2	Metformin (Glucophage)FDA LinkGeneric 01/2022 - 12/2016
2	Orlistat (Xenical)FDA Link 01/2018 - 07/2016
2	lamin CIBA 09/2017 - 05/2002
2	Biomarkers (Surrogate Marker)IBA 07/2017 - 09/2011
2	Lipoproteins (Lipoprotein)IBA 01/2017 - 08/2009
2	Pharmaceutical PreparationsIBA 12/2016 - 11/2011
2	Fenofibrate (CiL)FDA LinkGeneric 07/2016 - 07/2014
2	SubtilisinIBA 12/2012 - 05/2007
2	LDL Lipoproteins (beta Lipoproteins)IBA 12/2012 - 05/2007
2	Proprotein Convertases (Pro-Opiomelanocortin Converting Enzyme)IBA 12/2012 - 05/2007
2	Complement System Proteins (Complement)IBA 11/2011 - 12/2007
2	Protease Inhibitors (Protease Inhibitor)IBA 11/2011 - 09/2008
2	prelamin AIBA 04/2006 - 09/2005
2	LaminsIBA 04/2006 - 08/2003
2	Nonesterified Fatty Acids (NEFA)IBA 04/2006 - 01/2006
2	Cytoplasmic and Nuclear Receptors (Nuclear Receptors)IBA 01/2006 - 01/2006
2	AdiponectinIBA 03/2003 - 05/2002
1	Perilipin-1IBA 01/2022
1	Atorvastatin (Lipitor)FDA Link 01/2021
1	Simvastatin (Zocor)FDA LinkGeneric 01/2021
1	Growth Hormone (Somatotropin)IBA 08/2020
1	Apolipoproteins B (ApoB)IBA 01/2020
1	Proprotein Convertase 9IBA 01/2020
1	DysferlinIBA 12/2019

Therapy/Procedure

22	Therapeutics 01/2022 - 02/2002
4	Glycemic Control 01/2017 - 02/2002
2	Injections 12/2016 - 11/2011
2	Highly Active Antiretroviral Therapy (HAART) 12/2016 - 11/2011
2	Diet Therapy (Therapy, Diet) 07/2014 - 05/2014
1	Immunotherapy 01/2022
1	Secondary Prevention 01/2021